Pantoprazole
Short-Term Treatment of Erosive Esophagitis Associated with Gastroesophageal Reflux..., Maintenance of Healing of Erosive Esophagitis, Pathological Hypersecretory Conditions Including Zollinger-Ellison (ZE) Syndrome
Indications
- Short-Term Treatment of Erosive Esophagitis Associated with Gastroesophageal Reflux...
- Maintenance of Healing of Erosive Esophagitis
- Pathological Hypersecretory Conditions Including Zollinger-Ellison (ZE) Syndrome
Adult dosing
- erosive esophagitis: dose: 40; unit: mg; route: PO; interval: once daily for up to 8 weeks; fixed: true; labelExcerpt: Adults 40 mg Once Daily for up to 8 wks
Pediatric dosing
- erosive esophagitis 15 to 40kg: dose: 20; unit: mg; route: PO; interval: once daily up to 8 weeks (age >=5 y, 15 to <40 kg; 40 mg if >=40 kg); fixed: true; labelExcerpt: Children (5 years and older) ≥ 15 kg to < 40 kg 20 mg Once Daily for up to 8 wks
Renal adjustment
- Consult pharmacy/current label
Hepatic adjustment
- Consult pharmacy/current label
Contraindications
- Hypersensitivity to formulation or substituted benzimidazoles
- Patients receiving rilpivirine-containing products
Clinical pearls
- Do not split, chew, or crush delayed-release tablets.
- Use the lowest dose and shortest duration of therapy appropriate for the condition.
- Monitor for C. difficile-associated diarrhea and potential hypomagnesemia.
- Risk of osteoporosis-related bone fractures increases with long-term, multiple-daily dose therapy.
Source and review
- DailyMed label (pantoprazole sodium), Set ID 410d5577-e50a-44f3-aaa8-fbf391a0c261, effective 2026-10-13. Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties